Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...

RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $420 from $408 and keeps a Sector Perform rating on the shares.

Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.60% to $484.82 Monday, on what proved to be an all-around favorable ...

Vertex Pharmaceuticals Inc. closed 5.23% below its 52-week high of $519.88, which the company achieved on November 8th.

VertexOne, a leading provider of cloud software designed to revolutionize the customer experience within the energy and utility industry, announced today the appointment of Andrew Osler to its Board ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

Vertex Pharmaceuticals continues to see patients with sickle cell disease start the process to receive its Casgevy therapy, ...

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

Pilgrim, one of India's fastest-growing beauty and personal care brands, has successfully raised ₹200 crore in a mix of primary and secondary funding rounds. The round saw participation from existing ...

Macy’s is wedging itself into a popular novel based on women who shaped the department store business and adapting the bestseller by Julie Satow into a scripted television series. Satow’s book ...